$PMT

Citizens lowers PennyMac Mortgage stock price target on valuation

Citizens lowered its price target for PennyMac Mortgage Investment Trust (PMT) to $12.50 from $15.00, citing a revised price-to-book value multiple. The stock trades at $6.87, near its 52-week low, with a price-to-book ratio of 0.46. PMT reported Q2 2026 earnings of $0.23 per share, missing estimates. Analysts have mixed views, with UBS setting a $10.00 target and Deutsche Bank upgrading to Buy with a $12.00 target.

Original reporting
Published Oct 15, 2026, 9:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 9:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PMT
Bearish
high confidence
Mentioned
$PMT
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PMTBearishMed
01

Why it matters

The combined analyst downgrade and earnings miss create a bearish outlook for PMT in the near term.

02

Market read

Analyst target reduction and earnings miss are fresh, material news that could drive PMT lower in the short term.

03

What to watch

Potential upside from the company's shift toward higher‑yielding credit‑sensitive assets may not be fully priced yet.

Relevance 6/10Novelty 7/10Timing: today

Background

Citizens analyst Trevor Cranston cut PMT's price target and the firm posted Q2 earnings below forecasts, prompting mixed analyst reactions.

Company-level read

Ticker impact

$PMTBearishHigh confidence
Context

Citizens lowered its price target on PennyMac Mortgage Investment Trust to $12.50 and the company reported Q2 earnings that missed expectations.

Expected impact

likely pressure as the market prices in the lower target and earnings miss

Evidence & confidence

Analyst downgrade and a miss on EPS are fresh, material facts that typically drive the stock lower.

Market effects

Mortgage REIT sector may see broader scrutiny as earnings miss highlights rate‑sensitivity.

US mortgage‑backed securities could face tighter spreads.

Limited to US REIT investors; no major global ripple.

Counterpoint

The high dividend yield and deep discount to book could attract value‑seeking investors despite the short‑term miss.

Key entities

  • Citizens

    Provided the lowered price target and maintained Market Outperform rating.

  • PennyMac Mortgage Investment Trust

    Mortgage REIT that reported Q2 earnings miss and received a price target cut.

Related articles

$PMTMed

PennyMac Mortgage Investment Trust Reports Second Quarter 2026 Results

PennyMac Mortgage Investment Trust (PMT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PennyMac Mortgage Investment Trust Reports Second Quarter 2026 Results WESTLAKE VILLAGE, Calif. – July 29, 2026 – PennyMac Mortgage Investment Trust (NYSE: PMT) today reported net income attributable to common shareholders of $20 million, or $0.23 per common share on

$GEHCHighAI 9/10

GE HealthCare Q3 2026 slides: margin gains fuel guidance raise

GE HealthCare (GEHC) reported Q3 2026 revenue of $5.5B, up 6.2%, and EPS of $1.34, up 25.1%. The company raised full-year guidance due to margin expansion and operational improvements. Shares rose 6.9% to $76.02. All segments showed growth, with Pharmaceutical Diagnostics leading at 13.8%. Free cash flow increased to $793M. Guidance updated for higher revenue, EPS, and free cash flow.

$STGWMed

Stagwell earnings loom as investors watch media business revival

Stagwell Inc. reports Q3 earnings with analysts expecting $0.31 EPS on $838.4M revenue, up 27% and 13% YoY. Wall Street is bullish, with a $10.71 avg. price target. The company's media business revival and recent acquisitions, like Freestar, are key focuses. Stagwell's stock is up over 100% from its 52-week low, with investors watching for sustained growth.

$OSWHighAI 8/10

Why is OneSpaWorld stock surging today?

OneSpaWorld (OSW) stock rose 11.3% after reporting record Q3 results, with EPS of $0.34 and revenue of $276.5M, both beating estimates. The company announced a $100M share buyback and a 25% dividend increase. Net income and adjusted EBITDA also hit records, but Q4 guidance was slightly below consensus.

$AXGNHighAI 8/10

Why is Axogen stock surging today?

Axogen (AXGN) stock rose 21.8% after reporting Q3 2026 earnings and revenue beats, raising full-year guidance. Revenue grew 26.2% YoY to $75.8M, with breast reconstruction segment up 60%. The company also completed the BioCircuit Technologies acquisition and has $350.1M in cash. Full-year revenue guidance was raised to at least $290M.